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In this report, we describe a 61-year-old man that presented with isolated pulmonary vasculitis and
a positive anti-cyclic citrullinated peptide (CCP) antibody. Within a few months, the patient developed
the symmetric polyarthritis consistent with rheumatoid arthritis (RA). Because the anti-CCP antibody is
highly speciﬁc for RA and vasculitis is a known association of RA, we suspect the pulmonary vasculitis in
this patient was the ﬁrst manifestation of underlying RA. This case extends on previous reports that have
shown that lung disease may predate the development of articular RA and that anti-CCP positivity and
lung disease may represent a pre-RA phenotype. To our knowledge, this is the ﬁrst case report of pul-
monary vasculitis as the ﬁrst manifestation of RA.
 2013 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Lung disease occurs commonly in rheumatoid arthritis (RA), can
involve any of the lung compartments, is associatedwith signiﬁcant
morbidity and is the second leading cause of RA-associated mor-
tality.1 Pulmonary vasculitis, a rare manifestation of RA, is typically
identiﬁed in thosewith long-standing severe forms of RA.2 A recent
study has demonstrated that anti-cyclic citrullinated peptide (CCP)
positive individuals with airways or interstitial lung disease may
represent a pre-articular RA phenotype.3 In this report, we describe
a patient that presented with pulmonary vasculitis, and a positive
anti-CCP antibody; within a short period of time the patient
developed the symmetric polyarthritis of RA.2. Case presentation
A 61-year-old Caucasian man, with a remote eight pack-year
smoking history, seasonal allergies, gastroesophageal reﬂux dis-
ease, obstructive sleep apnea, and dyslipidemia presented with
pleuritic chest pain and dry cough of ﬁve months duration. There
was no improvementwith two courses of oral antibiotics. Therewas
no evidence of sinusitis, arthralgias, inﬂammatory arthritis, rash or
other symptoms of connective tissue disease. Physical examination
revealed a healthy, obese man with a normal set of vital signs and: þ1 303 398 1040.
.
-NC-ND license.resting room air pulse oximetry of 97%. Chest auscultation was
notable for inspiratory crackles at the right lung base. His muscu-
loskeletal and skin examinations were normal. Laboratory studies
demonstrated high-positive anti-CCP and anti-Ro (SSA) antibodies,
and a weakly positive rheumatoid factor (Table 1). Latent tuber-
culosis assessment was negative. Thoracic high-resolution com-
puted tomography (HRCT) imaging revealed several nodules and
thick-walled cavities predominantly in the right lung (Fig. 1). The
patient had a normal nuclear cardiac stress test, a negative ven-
tilation/perfusion scan and normal pulmonary physiology (Table 1).
Surgical lung biopsy revealed necrotizing granulomatous inﬂam-
mation with geographic necrosis, vasculitis and lymphocytic
pleuritis (Fig. 2) most compatible with an autoimmune-mediated
vasculitis.
After the lung biopsy, treatment with oral corticosteroids
(0.5 mg/kg/day prednisone) was initiated and the patient reported
rapid clinical improvement in respiratory symptoms. Two months
after lung biopsy, as corticosteroids were tapered; the patient
developed symmetric inﬂammatory polyarthritis involving the
small joints of the hands, wrists, and feet. Synovitis was identiﬁed
on physical examination. Plain radiographs of the hands and feet
were normal. Injectable methotrexate was initiated and rapidly
titrated to 25mgweekly. Corticosteroids were gradually tapered off
over the subsequent three months, and synovitis symptoms,
pleurisy, and cough remained quiescent. No new symptoms or signs
of systemic vasculitis have developed. A follow-up HRCT, reﬂecting
three months of therapy with corticosteroids and methotrexate
demonstrates that the pulmonary cavitary nodularity is gradually
Table 1
Initial laboratory and pulmonary function test results.
White blood cell count 8.3 K/mL
Hemoglobin 15.0 g/dL
Platelet count 198 K/mL
Serum creatinine 0.9 mg/dL
Albumin 4.5 g/dL
Alanine aminotransferase 28 IU/L
Erythrocyte sedimentation rate 18 mm/h
C-reactive protein 0.03 (normal  0.4)
Urinalysis No protein, red blood cells,
white blood cells, or casts
Anti-nuclear antibody Negative
Anti-Ro (SSA) antibody 132 units (negative  20)
Anti-La (SSB) antibody Negative






Rheumatoid factor 25 IU/mL (negative  14)
Anti-cyclic citrullinated peptide antibody 161 Units (negative  20)
Total lung capacity 8.0 L (125% predicted)
Forced vital capacity 4.4 L (96% predicted)
Forced expiratory volume in 1 s 3.4 L (100% predicted)
Diffusing capacity for carbon monoxide 35.1 ml/min/mmHg
(106% predicted)
Fig. 2. Photomicrograph (10) of histopathology specimen demonstrating necrotizing
granulomatous inﬂammation with geographic necrosis, and vasculitis.
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months after initiation of methotrexate was notable for persistent
high-positive anti-CCP and low-titer positive RF, and negativity to
anti-proteinase-3, anti-myeloperoxidase and C- and P-anti-neu-
trophil cytoplasmic antibody (ANCA).
3. Discussion
Vasculitis is a well recognized extra-articular manifestation of
RA; however, it is usually considered to be associated with long-
standing, severe, erosive, nodular, and sero-positive disease.2 RA-
vasculitis often manifests in the skin with pyoderma gan-
grenosum, nervous system with mononeuritis multiplex, or mayFig. 1. Initial high-resolution computed tomographic image demonstrating right lower
lobe nodular, cavitary lung disease.involve other organs such as the lungs. Because the current era
offers more effective disease modifying anti-rheumatic drug ther-
apies, RA-vasculitis is less commonly encountered.4e6
We believe this case represents pulmonary vasculitis as the
presenting manifestation of RA. A few factors argue in favor of such
a diagnosis: the presence of the high-titer anti-CCP; an autoanti-
body known to be highly speciﬁc for RA.7 The growing body of
evidence that anti-CCP antibody positivity and lung disease may
predate the articular manifestations of RA, and that such patients
may reﬂect a pre-RA phenotype.3,8,9 Our patient developed the
symmetric inﬂammatory polyarthritis and synovitis consistent
with RA. Finally, pulmonary vasculitis is a well known manifes-
tation of RA. Although the order of presentation e lungs before
joints e is atypical, the overall clinical scenario favors anti-CCP
positive RA with pulmonary vasculitis as the best unifying
diagnosis.
We can not fully discount the possibility that this case repre-
sents an atypical presentation of granulomatosis with polyangiitis
(GPA) (formerly Wegener’s). Indeed, inﬂammatory polyarthritis is
a common ﬁnding in patients with GPA.10 There are several aspects
of this case that argue against a diagnosis of GPA: the patient did
not have sinusitis or renal involvement; two features commonly
encountered in GPA.10 The patient was ANCA, proteinase-3, andFig. 3. Follow-up high-resolution computed tomographic image demonstrating mild
improvement in right lower lobe nodular, cavitary lung disease.
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speciﬁc autoantibody (anti-CCP).
In conclusion, this case reinforces the concept that a wide
spectrum of lung disease may be the presenting manifestation of
RA e including pulmonary vasculitis.
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